Novel psychoactive substances (NPS), also known as “designer drugs” or “research chemicals,” present a significant threat to public health worldwide. These substances are rapidly synthesized and here marketed, often without regulation, to circumvent existing drug regulations. Consumers may be unaware of the potential health risks associate